Healius Sells Lumus Imaging Unit to Affinity for $657 Million to Focus on Pathology Business
Healius Ltd. has agreed to sell its Lumus imaging division to Affinity Equity Partners for A$965 million ($657 million) as part of its strategy to concentrate on its pathology operations. The transaction, representing a multiple of 25.4 times full-year earnings before interest and taxes, is expected to yield